D Kim

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
    D Kim
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
    Leukemia 26:2538-45. 2012
  2. doi request reprint CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells
    D Kim
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Leukemia 26:2530-7. 2012

Collaborators

Detail Information

Publications2

  1. doi request reprint Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
    D Kim
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
    Leukemia 26:2538-45. 2012
    ..These results are consistent with the hypothesis that anti-CD47 blocking antibodies inhibit myeloma growth, in part, by increasing phagocytosis of myeloma cells...
  2. doi request reprint CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells
    D Kim
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA
    Leukemia 26:2530-7. 2012
    ..These results suggest that CD19(-)CD45(low/-) fully differentiated plasma cells enrich for long-lived and tumor-initiating cells whereas B cells or plasmablasts do not...